Role of p62 in aging-related disease

a technology of aging-related disease and p62, which is applied in the direction of peptides, drug compositions, metabolic disorders, etc., can solve the problems of many health problems, somatic damage, and become a significant human health problem

Inactive Publication Date: 2008-10-14
SHIN JAEKYOON +1
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The accumulation of somatic damage is considered a main cause of the aging process.
Obesity causes many health problems.
Obesity is the presence of excessive amount of adipose tissue and has become a significant human health problem in the modern world.
This results in elevated fasting and postprandial serum glucose that leads to complications if left untreated.
Ultimately, the β cell can no longer compensate, leading to impaired glucose tolerance, and diabetes.
A majority of individuals suffering from type 2 diabetes are obese, with central visceral adiposity, and an imbalance in energy intake and expenditure that leads to numerous metabolic abnormalities.
The major metabolic defects associated with insulin resistance are increased peripheral lipolysis, increased hepatic glucose output due to increased gluconeogenesis and increased lipid oxidation.
The oxidative stress produced by increased fatty acid oxidation may also produce additional harmful effects that amplify the disease process in the liver.
However, the questions of what determines the fate of a protein in relation to the formation of such abnormal inclusion bodies and what would be the pathologic impact of inclusion bodies in neuro-degeneration process remain unclear.
Aging-related disorders, such as formation of intracellular inclusions, obesity, diabetes, cancer, in particular, liver cancer, fatty liver, Paget Disease of Bone, and early mortality for male continue to pose significant health problems.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Role of p62 in aging-related disease
  • Role of p62 in aging-related disease
  • Role of p62 in aging-related disease

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation of p62 Knockout Mice

[0280]A. Isolation of a p62 Genomic Clone

[0281]The human p62 gene was isolated as shown in U.S. Pat. No. 6,291,645, which is incorporated by reference in its entirety for its disclosure of the cloning and sequencing of the p62 gene. Genomic DNA clones corresponding to p62 locus in mice were cloned from a RPCI 22 mouse BAC library prepared from mouse strain 129 / svEvTACCfBr (Invitrogen).

[0282]B. Preparation of p62 Knockout Targeting Vector

[0283]To produce a null allele of p62, a gene targeting vector was prepared as shown in FIG. 1. p62 genotypic analysis of litters through PCR analysis of litters derived from heterozygote intercross, as well as through Southern blot and immunoblot analysis of extracts from wild or null p62 mice organs show that the targeted gene was disrupted. The targeting vector was constructed by inserting a 2.3 kb EcoRI-BamHI amplified from the 5′ end of the p62 genomic clone into EcoRI-BamHI site of pPNT. A 4.0 kb SspI fragment de...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
concentrationsaaaaaaaaaa
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
Login to view more

Abstract

The application discloses a role of p62 in aging-related disease, such as development of obesity, type 2 diabetes mellitus, non-alcoholic fatty liver, various tumors, increased male mortality, intracellular inclusion named sequestosome, and redox regulation. In particular the application discloses a method of detecting the formation of inclusion bodies in neurodegenerative diseases. The invention further relates to a method of screening for therapeutic agents that disperse the inclusions. Further, transgenic mice containing a mutation in the p62 gene and having a functionally disrupted p62 gene locus are also disclosed.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]The present invention claims priority to U.S. provisional application No. 60 / 378,159, field May 14, 2002, which is incorporated herein by reference in its entirety.BACKGROUND OF THE INVENTION[0002]1. Field of the Invention[0003]The invention relates to a method of detecting the formation of inclusion bodies such as sequestosomes. The invention also relates to a method of detecting inclusion bodies in neurodegenerative diseases. The invention further relates to a method of screening for therapeutic agents that disperse the inclusions.[0004]The invention relates to transgenic non-human animals and transgenic non-human animal cells harboring a transgene containing a mutation in the p62 gene and having a functionally disrupted p62 gene locus. The invention further relates to transgenes and targeting constructs used to produce such transgenic animals and cells, methods of using such animals for modeling aging related disorders, and methods for...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(United States)
IPC IPC(8): A01K67/00A01K67/027A01N63/00C12N15/00C12N15/63G01N33/68A61P3/10A61P19/08A61P25/28C07K14/47C12Q1/68
CPCC07K14/4702C12Q1/6883A01K2217/075C12Q2600/158C12Q2600/136C07K2319/60A61P19/08A61P25/28A61P43/00A61P3/10G01N33/68
Inventor SHIN, JAEKYOONLEE, HAN-WOONGOH, GOO TAEG
Owner SHIN JAEKYOON
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products